VISTEON CORP (VC)
Sector: Consumer Discretionary
| Ticker | Position | Age | Qualifications and Experience | Committee Memberships | Filing Year |
|---|---|---|---|---|---|
Sector: Consumer Discretionary
| Ticker | Position | Age | Qualifications and Experience | Committee Memberships | Filing Year |
|---|---|---|---|---|---|
Director information for VC
| Ticker | Position | Age | Qualifications and Experience | Committee Memberships | Filing Year |
|---|---|---|---|---|---|
| VC | Former Managing Director, Farallon Capital Management, LLC | 65 | ["Managing Director of Farallon Capital Management, LLC","Chief Financial Officer of eGroups, Inc.","Chief Financial Officer of Amylin Pharmaceuticals, Inc.","Experience as a member of the Board of Directors of Cognex Corporation","Public board experience","Extensive knowledge of corporate finance and financial reporting","Financial leadership in fast-growing companies in the technology and biotechnology sectors","Experience as an institutional investor"] | ["Audit Committee"] | 2026 |
Companies shown below are based on exact name match for the selected Director
| Ticker | Position | Age | Qualifications and Experience | Committee Memberships | Filing Year |
|---|---|---|---|---|---|
| CGNX | Independent Director | 65 | ["Executive leadership experience: Held CFO role at fast-growing companies in the technology and healthcare industries, including organizations focused on digital communication platforms and biotechnology","Public company board experience: Has served for over ten years on various boards, including three public company boards, and in multiple roles on committees","Extensive knowledge of corporate finance, financial reporting, and institutional investing: Former CFO of public and private companies who co-led IPOs, follow-on offerings, and M&A transactions and gained deep capital markets and operations expertise; accomplished institutional investor in publicly traded securities"] | ["Audit (Chair)"] | 2026 |
| QNST | Director | 58 | [] | [] | 2018 |
Biography sourced from the proxy statement filing.
Ms. Sennett served as Managing Director of Farallon Capital Management, LLC, an institutional asset management firm, from 2004 until her retirement in June 2009. She initially joined Farallon in 2001 as a senior research analyst and consultant. Earlier in her career, Ms. Sennett was Chief Financial Officer of eGroups, Inc., where she co led the company s sale to Yahoo! Inc., and Chief Financial Officer of Amylin Pharmaceuticals, Inc., where she led the company s initial public offering and subsequent follow on equity offerings. Ms. Sennett also serves as a member of the Board of Directors of Cognex Corporation. Ms. Sennett brings public board experience, extensive knowledge of corporate finance and financial reporting, financial leadership in fast-growing companies in the technology and biotechnology sectors, and experience as an institutional investor.